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Abstract.  Early development of the urodele amphib- 
ian Pleurodeles waltl is accompanied by a process of 
progressive fibronectin (FN) fibrillogenesis.  FN begins 
to assemble into fibrils on the inner surface of the 
blastocoele roof at the early blastula stage and pro- 
gressively forms a complex extracellular matrix.  We 
have analyzed the mechanisms of FN-fibril formation 
under normal and experimental conditions in vivo 
with the following probes: iodinated FN, fluorescein- 
labeled FN,  synthetic peptides containing the Arg-Gly- 
Asp (RGD) cell surface recognition sequence of FN, 
and polyclonal antibodies against both/3~  subunit of 
the amphibian FN receptor and the cytoplasmic do- 
main of/3~  subunit.  We report that in living embryos, 
exogenous labeled mammalian  FN injected into the 
amphibian blastocoele undergoes FN-fibril formation 
in spatiotemporal patterns similar to those of endoge- 
nous FN.  This indicates regulation of fibrillogenesis 
by the cell surface rather than by changes in the type 
of FN.  Fibrillogenesis is inhibited in a dose-dependent 
manner both by the GRGDS peptide and monospecific 
antibodies to amphibian  integrin/3~  subunit.  Further- 
more,  when injected intracellularly  into uncleaved em- 
bryos or into selected blastomeres, antibodies to the 
cytoplasmic domain of integrin/~t  subunit produce a 
reversible inhibition  of FN-fibril formation that follows 
early cell lineages and cause delays in development. 
Together,  these data indicate that in vivo, the integrin 
/3t  subunit and the RGD recognition signal are essen- 
tial for the proper assembly of FN fibrils in early am- 
phibian development. 
T 
hE  regulation  of extracellular  matrix  assembly and 
cellular responses to these matrices are important for 
the control of morphogenesis and organogenesis.  For 
instance,  cell morphology,  cell attachment and migration, 
tissue stability, cell polarity, and differentiation often require 
adhesion and specific interactions  of a cell with its substra- 
tum. These interactions  involve specific cell surface proteins 
that bind adhesive ligands of the extracellular  matrix.  A fam- 
ily  of proteins  that  appears  to provide  such  functions  is 
known  as the integrin  superfamily  (Hynes,  1987).  Protein 
and cDNA sequencing of these receptors as well as immuno- 
logical analysis have established the existence of two multi- 
gene families of glycoproteins detected throughout the animal 
kingdom corresponding to integrin ot or # subunits (Tamkun 
et al., 1986; Argraves et al., 1987; Suzuki et al., 1987; DeSi- 
mone  and  Hynes,  1988;  Marcantonio  and  Hynes,  1988; 
Cheresh et al.,  1989). These families are divided into dis- 
tinct subfamilies, in which members share a common/3 sub- 
unit that is noncovalently combined with a unique ot subunit 
to form or//3 heterodimers.  The ~ subunit appears to confer 
ligand-binding  specificity. To date,  three major subfamilies 
have been described: the leukocyte adhesion  proteins  (Leu- 
CAM) (Anderson  and Springer,  1987), cytoadhesins (Gins- 
berg et al., 1988), and the very late antigens (VLAs) t (Hor- 
witz  et al.,  1985).  The  integrin  VLA family  consists  of 
heterodimers of six different ot subunits each associated with 
a common/3~ chain.  The VLA-5 molecule (t~sB~) is directly 
implicated  via its extracellular  domain in the recognition  of 
fibronectin  (FN) (Pytela et al.,  1985; Wayner et al.,  1988; 
Akiyama et al.,  1989a).  However,  several  other integrins 
also bind fibronectin,  including  c~3/3t, ~llb~3, and ~v/3x. The 
relationship  between these FN adhesion  receptors and FN 
matrix  assembly remains  uncertain at present (reviewed in 
McDonald,  1988 and Akiyama et al.,  1989b). 
At  the  molecular level,  FN matrix  assembly could be 
modulated by at least three events (McDonald, 1988; Ruos- 
lahti,  1988): the binding  of FN to one or more cell surface 
receptors, FN-FN binding, and finally FN-FN cross-linking 
and fibril elongation through  both disulfide bond formation 
and the action of a transglutaminase  (McKeown-Longo and 
1. Abbreviations used in this paper: FN, fibronectin; MBS, 10% modified 
Barth solution; RLDx, lysinated rhodamine dextran; VLA, very late an- 
tigen. 
©  The Rockefeller  University  Press, 0021-9525/90/05/1813/11  $2.00 
The Journal  of Cell Biology,  Volume 110, May  1990 1813-1823  1813 Mosher,  1984;  Homandberg and Erickson, 1986).  For the 
first event, two cell surface receptors have been proposed: 
the FN cell adhesion receptor (an integrin) and a "matrix as- 
sembly receptor."  Previous studies suggest that the RGD- 
containing cell adhesive domain and its integrin receptor 
may cooperate in FN-fibril assembly. For example, onco- 
genic transformation produces a  loss of FN matrix and a 
diffuse distribution of FN receptors; on FN substrata, cells 
exhibit extracellular FN fibrils that colocalize with the FN- 
receptor complex (Chen et al., 1985; Damsky et al., 1985); 
RGD-containing peptides that induce detachment of fibro- 
blasts from extracellular FN matrix lead to diffuse receptor 
localization (Chen et al.,  1986);  and particularly impor- 
tantly, cell adhesive fragments, anti-FN and anti-otsB~ anti- 
bodies that inhibit the binding of FN to its receptor, block 
FN-fibril  formation by cultured fibroblasts (McDonald et 
al.,  1987; Akiyama et al.,  1989a;  Roman et al.,  1989). 
On  the  other  hand,  evidence  for the  matrix  assembly 
receptor identified by McKeown-Longo and Mosher (1983) 
appears equally compelling, although its molecular compo- 
sition  remains  unclear.  This  postulated  matrix  assembly 
system appears to be primarily dependent on the amino-ter- 
minal domain of FN, a region that has little or no cell adhe- 
sive activity (McKeown-Longo and Mosher, 1983, 1985, 1988; 
Peters and Mosher, 1987; McDonald, 1988).  Furthermore, 
heparan sulfate proteoglycan may also be implicated in ma- 
trix deposition and attachment of fibroblasts (Woods et al., 
1986).  A transmembrane heparan sulfate proteoglycan that 
binds to FN has been isolated (Rapraeger et al., 1986).  Fi- 
nally, a severely ganglioside-deficient cell line does not as- 
semble FN into a matrix, and matrix assembly is restored 
by certain exogenous gangliosides, implicating gangliosides 
in this process as well (Spiegel et al.,  1985;  1986). 
In early amphibian development, an extracellular matrix 
containing FN fibrils undergoes assembly at the basal sur- 
face of  cells that form the blastocoele roof (Boucaut and Dar- 
rib~re,  1983; Darrib~re et al., 1984,  1985; Johnson, 1981, 
1985; Johnson et al.,  1990;  Lee et al.,  1984;  Nakatsuji et 
al., 1982,  1985). During gastrulation, these FN fibrils pro- 
vide a substrate for mesodermal cell migration (Boucaut et 
al., 1984a,b; Nakatsuji and Johnson, 1984a,b).  Furthermore, 
immunological inhibition studies performed in vitro and in 
vivo, demonstrate that a complex of glycoproteins of 90-140 
kD is involved in the binding of mesodermal cells to FN 
fibrils (Darrib~re et al.,  1988). 
An important and still unanswered question concerns the 
actual  mechanism  of cell  interactions  with  FN  to  form 
fibrils, as well as its regulation. We focused on the possibility 
that the/~ subunit found in the integrin VLA-5 may medi- 
ate or modulate these interactions. We initiated experiments 
to analyze the matrix assembly activity of  blastomeres in liv- 
ing amphibian embryos. We have used RGD-containing pep- 
tides and both antibodies to the whole molecule or the cyto- 
plasmic domain of the  integrin ~  subunit to perturb  its 
function. Our major findings are that exogenous FN incorpo- 
ration into chimeric matrices is regulated in parallel with en- 
dogenous fibrillogenesis, and that RGD-containing peptides, 
polyclonal Fab' fragments of IgG to both the amphibian inte- 
grin /~  subunit (extracellularly), and the cytoplasmic do- 
main of 8, (intracellularly) cause specific in vivo inhibition 
of the ability to incorporate labeled exogenous FN into ex- 
tracellular matrices and to elaborate endogenous FN fibrils. 
Materials and Methods 
Embryos 
Embryos of the urodele amphibian Pleurodeles wald Michah were collected 
from natural matings. They were manually dejellied and maintained at 18°C 
in 10% modified Barth solution (MBS) (Barth and Barth, 1959) containing 
50 ~g/ml gentamycin (Gibco Laboratories, Grand Island, NY).  Develop- 
mental stages of embryos were according to Gallien and Durocher (1957). 
Purification of Fibronectin 
FN was prepared from fresh-frozen bovine plasma by gelatin-Scpharose 
affinity chromatography (Engvall and Ruoslahti,  1977). Purity of FN was 
assessed by SDS-PAGE. If needed, FN was further purified using two cycles 
of gelatin-Sepharose chromatography. 
Labeling of Fibronectin 
Purified bovine plasma FN was labeled with lesI or FITC. The iodination 
of FN was carried out with Bolton and Hunter (1973) reagent (74 TBq/ 
mmoi; Amersham Corp., Arlington Heights, IL). By SDS-PAGE, the iodi- 
nated material migrated as a doublet at an apparent molecular mass of 220 
kD under reducing conditions. For FITC labeling, FN in a 0.1  M sodium 
carbonate/bicarbonate buffer (pH 9) was incubated with FITC (200/~g/mg 
of FN; Sigma Chemical Co.; St. Louis, MO) for 2 h at room temperature 
and with gentle stirring (Che.rnousov et al.,  1985). Unreacted dye was re- 
moved by gel fltration on Sephadex G-50 eluted with MBS. For control ex- 
periments, BSA (fraction V; Sigma Chemical Co.) was labeled identically. 
Iodinated and fluorcscein-conjugated FNs retained their biological activity 
in cell spreading.assays described previously (Darrib6re et ai.,  1988). 
Purification of lntegrin ~1 Subunits 
Batches of 1,000 larvae (stage 39) of Pleurodeles waltl were homogenized 
in a Polytron (12,000 rpm,  1 rain, 4°C; Bioblock Scientific, France) in 40 
mM octyl-/~-glucopyranoside (OGP; Calbiochem-Behring Corp., San Diego, 
CA), 2 mM PMSF, 2 mM EGTA, 5 tzg/ml aprotinin, 0.5/tg/ml leupeptin, 
50 mM Tris-HCI pH 7.4 (buffer 2). Detergent extraction of proteins was car- 
ried out for 2 h at 4°C with stirring. Detergent-insoluble material was re- 
moved by centrifugation at 12,000 g for 15 min at 4°C. The resulting super- 
natant solution was incubated with Sepbarose 4B beads (10 ml of packed 
beads; Pharmacia Fine Chemicals, Piscataway, NJ) for 1 h at 4oc in order 
to remove proteins that bind nonspecifically to Sepharose 4B. After sedi- 
mentation, the supernatant solution was mixed overnight at 4°C by end- 
over-end rotation with 10 ml packed volume of concanavalin A-Sepharose 
4B (Sigma Chemical Co.). Bound proteins were eluted with 0.25 M t~-meth- 
yl-D-mannoside (Sigma Chemical Co.)  in buffer.  Fractions that react by 
immunoblotting with anti-avian integrin IgG  were pooled  and dialyzed 
against buffer 2 at 4°C.  They were then incubated with the IgG .fractions 
of polyclonal antibodies against avian integrin VLA-5 coupled to CNBr- 
activated Sepharose 41] (Pharmacia Fine Chemicals) at a ratio of 5 mg anti- 
bodies per l  ml of packed beads according to Hasegawa et al. (1985). 
Antibodies and Peptides 
Antibodies against the integrin/31  subunit of Pleurodeles waltl (anti-/J0 
were raised in New Zealand white rabbits. Subcutaneous injections using 
0.2 nag of amphibian integrin ~j emulsified 1:1 with Freund's complete or 
incomplete adjuvant were administered at 1-wk intervals. Rabbits were bled 
from an artery  and IgG were purified  from sera by chromatography on 
DEAE  TrisacryI-M as recommended by the manufacturer (Indnstrie Bi- 
ologic Franeaise,  France).  Polyclonal antibodies against the cytoplasmic 
domain of integrin/~l subunit (anti-/31 COOH) were produced by immuniza- 
tion of a rabbit with a synthetic peptide with the sequence CKLLMIIHDR- 
REFAKFEKEKM NAKW DTGEN PIYKSAVTTV VNPKYEGK  (DcShnone 
and Hynes,  1988). The peptid¢ was conjugated to keyhole limpet haemo- 
cyanin (Pierce Chemical Co., Rockford, IL) with the heterobifunctional re- 
agent m-maleimidobenzoic acid-N-hydroxysuccinimide ester (MBS; Pierce 
Chemical Co.) essentially as described (Walker et al., 1985). This antibody 
immunoprecipitated the same human fibroblast intngrins as an existing anti- 
El  monoclonal antibody (Akiyama et al.,  1989a),  and showed the same 
immunoiocalization pattern; it also stained/~t  and pre~t  subunits as ex- 
pected in Western immunoblots of fibroblast extracts. Production of rabbit 
IgG fractions of polyclonal antibodies toAmbystoma mexicanum plasma FN 
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(A) Immunoprecipitation of [3SS]methionine-labeled proteins from 
Pleurodeles waltl  midgastrula embryos with anti-FN IgG. Precipi- 
tation was performed with protein A-Sepharose (5 mg) and 30 ttg 
of IgG. Sample was analyzed by 7.5 % SDS-PAGE under reducing 
conditions. A doublet with an apparent molecular mass of  220 kD is 
clearly detectable. (B) Immunoprecipitation of embryonic [3SS]me- 
thionine-labeled proteins with 5 mg of protein A-Sepharose and 30 
/~g of anti-amphibian integrin/31  subunit IgG (lane 1) or IgG a~inst 
the cytoplasmic domain of integrin/~1  subunit  (lane 2).  Samples 
were analyzed by 7.5% SDS-PAGE under nonreducing conditions. 
Controls were performed with protein A-Sepharose alone (lane 3) 
or IgG preincubated with amphibian integrin ~, subunit (lane 4). 
The autoradiogram indicates that both antibodies recognize the am- 
phibian  integrin fl~  subunit  of 100 kD.  The faintly labeled poly- 
peptides of 140 kD represent integrin a  subunits. They are noncova- 
lently associated with integrin/~  suhtmits and axe coprecipitated 
with/31  subunits.  Mr, molecular mass markers  in kilodaltons. 
(anti-FN)  has been previously described  (Boucaut and Darrib~re,  1983). 
The specificity of IgG fractions was evaluated by immunopreeipitation and 
SDS-PAGE using [~$lmethionine-labeled whole embryo homogcnates (Fig. 
1). Furthermore, anti-#~ lgG inhibit mesc~rmal cell attachment and spread- 
ing on FN-coated substrata.  Monovalent  fragments  of these antibodies 
(Fab') were prepared according to Brackenbury et at. (1977). Their purity 
was tested  by SDS-PAGE. For control  experiments  we used nonimmnne 
Fab', or we attempted to block the activity of Fab' fragments with antigen. 
In the later case, anti-~ FalY  or anti-/~s COOH FaN were mixed with puri- 
fied amphibian integrin/31 subunit at a weight ratio of 1:1 in sterile 10% 
MBS. Both control probes were used immediately after low speed centrifu- 
gation (1,000 g, 10 min) to sediment insoluble material. Control blastomere 
injections were also performed with IgG fractions from rabbit, mouse, and 
human sera. 
The synthetic peptides used were Gly-Arg-Gly-Asp-Ser (GRGDS), and 
Cys-GIn-Asp-Ser-Glu-Thr-Arg-Thr-Phe-Tyr (P2). They correspond  to con- 
served  and  hydrophilic  sequences  from,  the celt-binding  and  collagen- 
binding  sites  of FN, respectively  (Yan~da  and Kennedy,  1984; Piersch- 
bather and Ruoslahti,  1984). 
Metabolic Labeling, lmmunoprecipitation, 
and Electrophoresis 
Embryos  at  midgastrula  stage  (stage  10)  were  injected  with  5  nl  of 
[35S]methionine (555 MBq/ml; Amersham Corp.)  and allowed to develop 
in 10% MBS for 4-6 h.  They were then homogenized in buffer 3:0.1 M 
NaC1, I taM MAC12, 40 mM OGP, 2 mM PMSE 5 t~g/rnl aprotinin,  0.5 
ttg/ml leupeptin, 50 mM Tris-HCl, pH 7.4, and extracted for 15 min at 4"C. 
Yolk and insoluble materials were removed at 10,0{30 g for 30 rain at 4°C. 
lmmunoprecipitations  of FN, or of integrin/3,  subunit were performed 
with protein  A-Sepbarose  CL-4B (Pharmacia  Fine Chemicals).  Nonspe- 
cific binding sites on beads were quenched by preincubating the beads with 
unlabeled extracts of  embryonic proteins for I h at room temperature. Then, 
5 mg of beads were incubated with 30 p.g of the appropriate  lgG in  1 ml 
of butler 3 for 1 h at room temperature with stirring. After two washes with 
buffer 3, the beads were incubated with 1 ml of radioactive protein extract 
from 10 embryos overnight at 4"C with gentle stirring. After 10 washes with 
buffer 3, immunoprecipitates  were analyzed by SDS-PAGE (Darrib~re et 
al., 1988). Gels were stained with Coomassie blue, processed for fluorogra- 
phy using Amplify (Amersham Corp.),  dried,  and exposed with an inten- 
sifying screen (Dupont Lightning Plus, France)  using Kodak XAR t~tm. 
Injections 
Embryos  with  diameter  from  1.2 to  1.4 mm were collected  when  they 
reached the uncleaved, 2-cell, early, mid-, or late blastula stage (stages 0, 
1, 5, 6, 7) and injected into blastomeres or the balstocoele.  Iodinated FN, 
FITC-FN, or FITC-BSA were  injected  into  early  blastula  blastocoeles 
(stage 5) in the absence or presence of peptides, anti-/3~ Fab', or preimmune 
antibodies.  For injections, 200 nl of the blastocoele fluid was removed to 
prevent any overpressure during  injection.  Thereafter,  200 nl of a 0.05-1 
mg/ml  solution of reagents dissolved  in  10% sterile MBS were injected 
(final amount per embryo:  10-200  rig). After injections embryos were in- 
cubated for 2, 4, 6, and 18 h in 10% MBS at 18"C. At each time, embryos 
were dissected in sterile MBS into animal (blastocoele roof, AP) and vege- 
tal halves (VP).  After careful washes, labeled FN binding was examined 
in both halves by immune precipitation,  counting radioactivity, or direct 
fluorescence. 
Anti-/3m COOH Fab' were introduced  into nncleaved embryos (stage 0) 
or one blastomere of two-cell embryos (stage 1). Injections into uncleaved 
embryos were performed in the equatorial region and at least 3 h after fertil- 
ization.  Uncleared  embryos  were injected  with  10-50  nl  (i.e.,  roughly 
1/20-1/100 of the egg volume) of 0.05-10 mg/ml solutions of antibodies dis- 
solved in 10% sterile MBS (final amount: 0.5-500 rig/embryo). Injections 
into biastomeres were performed  with a volume of 5-30 rd (i.e., roughly 
1/50-1/100 of the blastomere volume) of the same antibody solutions (final 
amount: 0.25-300 ng/blastomere) except that they  also contained 50 mg/ml 
of lysir~ted rhedamine dextran (RLDx) (Gimlieh and Cooke,  1983) to fol- 
low the fltte of OffSpring of the injected biastomvre.  After injections, em- 
bryos were reared in 10% MBS at 18°C in the dark to minimize bleaching 
of the fluorescent dye. Embryos were dissected and fixed for whole-mount 
studies of FN-fibril formation. 
Immunofluorescence and Scanning 
Electron Microscopy 
For whole-mount observations,  the roof of the blastocoele  was dissected 
from 124 cells to late gastrulae (stage.s 4-13) after removal of the viteiline 
membrane. Then, the explants were treated for immunodetection of FN as 
described previously (Boucaut and Darrib~re, 1983). Scanning electron mi- 
croscopy was carried out according  to Nakatsuji et al.  (1982). 
Results 
l~bronectin-fibril Formation 
The time course and pattern of normal in vivo fibril forma- 
tion was established by indirect immunofluorescence for FN. 
When  the blastocoele begins  to  form in the eight-cell em- 
bryos (stage 3), there is no fluorescence for FN on the inner 
surface  of  blastomeres at  the  animal pole.  In  morulae  (stage 
4), no FN fibrils  were yet  observed. However, nonfibrillar 
fluorescent  labeling  was detected  either  as a ring  around 
blastomeres near  cell-cell  contacts  or  as  minute  speckles  on 
the  surface  of  each  blastomere (Fig.  2  A).  The  first  FN fibrils 
were observed 2 h later  in early  blastulae  (stage  5). They 
were located  primarily  at  the  edges of  the  smallest  cell  sur- 
faces  of  the  blastocoele  roof  (Fig.  2  B).  In  midblastulae  (stage 
6), fibrils  appeared all  around the  cell  periphery.  They also 
Darril~re et al. lntegrin f3  t Subunit Function  1815 Figure 2. Time course analysis of  FN-fibril formation. Whole mounts of the blastocoele roof from Pleurodeles waltl  embryos were analyzed 
by indirect immunofluorescence with purified anti-FN IgG. (A) Inner face of  blastocoele roof of  morula stage (stage 4). Fluorescent staining 
is observed at areas of cell-cell contacts and more weakly on the cell surface. No FN fibrils are detected at this stage. (B) Early blastula 
stage (stage 5).  Inner view of the blastocoele  roof in the animal pole region.  A faint fluorescent ring delineates blastomeres.  The first 
FN fibrils appear at some blastomere edges. (C) Midblastula stage (stage 6). Fibrillar arrays of  FN staining are concentrated at the periphery 
of blastomeres. (D) Late blastula stage (stage 7). FN fibrils extend from the cell periphery toward a central supranuclear zone. (E) Midgas- 
trula stage (stage 10). A complex extensively anastomosed meshwork of FN covers the entire inner surface of the blastocoele roof. Bar, 5 #m. 
crossed  adjacent  cell  boundaries  (Fig.  2  C).  They  were 
smaller than those occurring at first and arranged perpendic- 
ular to the plane of contact between blastomeres. Within a 
span of ,o6 h,  fibrils elongated from these peripheral sites 
toward the central portion of cell surface over the nucleus. 
In late blastulae (stage 7), fluorescent staining for FN was 
now well developed over most of the cell (Fig.  2  D).  FN 
fibrils were still more abundant at the periphery of each cell. 
At this stage, two kinds of fibrils can be distinguished:  the 
first were short and thin,  and the second were longer and 
thicker. 24 h after fertilization, in early gastrulae (stage 8a), 
FN fibrils formed a complex anastomosing fibrillar matrix, 
which covered the entire inner surface of the blastocoele roof. 
During gastrulation, the extracellular meshwork o.f FN fibrils 
showed further increases in density (Fig.  2  E). 
Exogenous Fibronectin-Fibril Formation 
We tested the hypothesis that the time course and pattern of 
FN assembly was independent of the FN molecules them- 
selves using interspecies injections.  Exogenous labeled FN 
was injected into the blastocoele of early blastula (stage 5), 
when few fibrils are present (Fig, 2 B). The binding of FN 
was studied with iodinated FN to quantify binding and with 
FITC-FN to localize injected FN. 
The  t25I-FN binding was examined by immunoprecipita- 
tion and SDS-PAGE.  Autoradiograms revealed that ~25I-FN 
was  bound  preferentially  to  the  animal  hemisphere.  The 
polypeptides corresponding to FN were detected from 2 to 
18 h after the injection in the animal half of embryos. The 
incorporation of FN  increased  in time-dependent fashion. 
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Figure 3. Time course of incorporation of 'zSI-FN into Pleurodeles 
waltl embryos. (.4) The same amount of 125I-FN (50 #g/ml,  200 
nl, 100,000 cpm) was injected into the blastocoele of early blastula 
embryos (stage 5). At each designated time point, 10 embryos were 
dissected into animal (AP) and vegetatal (VP)  hemispheres. Radio- 
activity was determined for the two samples and presented as cpm/ 
embryo. As a control for specific binding, labeled FN was injected 
in the presence of excess unlabeled FN (200/~g/ml), and the resul- 
tant binding to AP hemispheres is shown (~25I-FN +  FN). In the 
presence of this excess unlabeled FN, binding is minimal. In con- 
trast, the curves show a time-dependent incorporation of iodinated 
FN especially into AP compared with VE Determinations repre- 
sent averages from triplicate experiments. (B) The same quantities 
of ~z~I-FN (50 pg/ml, 200 nl, 100,000 cpm) were injected into the 
blastocoele of early blastula embryos (stage 5) with control peptide 
P2 (200 #g/ml), GRGDS (200 #g/ml), or anti-/~ Fab' (250 pg/ml). 
At the designated time points,  10 animal hemispheres were bis- 
sected and radioactivity was determined. The data represent the av- 
erage of three experiments. They reveal a significant inhibition of 
incorporation of exogenous FN by either GRGDS or monovalent 
anti-/~ antibodies. Controls were carried out with P2 correspond- 
ing to the collagen binding domain of FN or anti-/~, Fab'  absorbed 
with amphibian/31 subunits (Anti-Bt +/Yt). 
Conversely, virtually  no  incorporation of labeled-FN oc- 
curred  in  the  vegetal  half of embryos.  As  a  control  for 
specific binding of '25I-FN, embryos (stage 5) were injected 
with a mixture of labeled (50 #g/ml, 100,000 cpm) and unla- 
beled FNs (200 ftg/ml). No trace of FN could be detected 
on autoradiograms even after lengthy exposure of the gels 
(data not shown). 
Bound FN was also measured by counting the radioactiv- 
ity in the two embryonic halves. As shown in Fig. 3 A, iodi- 
nated bovine plasma FN bound to the blastocoele roof. The 
binding was time dependent, In contrast, the binding of ex- 
ogenous  FN  to the  vegetal half occurred at  substantially 
lower rates throughout the period of incubation. Addition of 
excess unlabeled FN (200 ttg/ml), dramatically reduced the 
binding of '25I-FN to the animal hemisphere (Fig.  3 A). 
To determine where exogenous FN bound to the animal 
half, FN was also monitored by fluorescein labeling. Experi- 
ments were done with different concentrations of FN ranging 
from 10 to 100 #g/ml. Optimal incorporation was observed 
with 50 ftg/ml. The results show that exogenous FN is trans- 
ferred to the extracellular matrix with the same timing and 
pattern as endogenous FN. Fluorescent fibrils were absent 
in controls where FITC-FN were mixed with an excess of un- 
labeled FN (200/zg/ml) or where FITC-BSA was injected. 
When surfaces of endodermal cells facing the blastocoele 
were observed, no fibrils could be detected with FITC-FN 
even after 18 h of incubation. Furthermore, at late blastula 
stage (stage 7), when the extracellular matrix of the blasto- 
coele roof was transferred onto slides (Shi et al.,  1989) and 
incubated for 18 h with FITC-FN, no fluorescent fibrils were 
detected, suggesting that cellular processes mediate fibrillo- 
genesis (data not shown), 
Inhibition of  Fibronectin-fibril Formation by 
GRGDS and Anti-integrin [3l Subunit Antibodies 
Applied Extracellularly 
Iodinated or fluoresceinated FN was injected into the blasto- 
coele of early blastula (stage 5) in presence of either GRGDS 
or monovalent antibodies against  integrin/~  subunit.  The 
binding of FN was assessed by immune precipitation, count- 
ing of radioactivity, and immunofluorescence. 
Immunoprecipitation followed by SDS-PAGE and autora- 
diography  demonstrated  that  GRGDS,  as  well  as  anti-/~, 
Fab', inhibited the binding of FN to the roof of the blasto- 
coele. Indeed, no trace of radioactive FN could be detected 
in presence of GRGDS or anti-/~, FalY even after an 18-h in- 
cubation. In contrast, polypeptides corresponding to FN were 
revealed after incubations with the collagen binding site of 
FN (peptide P2). 
Quantitative radioactivity binding data were obtained for 
blastocoele roof and vegetal hemisphere. The results con- 
firm that both GRGDS and anti-~ Fab' substantially inhibit 
the binding of '=I-FN t0 blastomeres of the blastocoele roof. 
As shown in Fig. 3 B, the incorporation of '25I-FN was min- 
imal in the presence of GRGDS or anti-/~, Fab' when com- 
pared with control experiments performed with peptide P2 
or FalY absorbed with the integrin antigen. 
Finally, in fluorescence localization studies with FITC-FN 
(50/~g/ml), FN did not become organized into fibrils when 
incubated with either GRGDS (200 pg/ml) or anti-/3,  Fab' 
(250 ftg/ml). Conversely, FN-fibril formation occurred nor- 
mally in the presence of collagen-binding peptide P2 (200 
#g/ml) (data not shown). 
Inhibition of Fibronectin-fibril Formation by 
Intracellular Injection of  Antibodies to Cytoplasmic 
Domain of  lntegrin {3t Subunit 
Since FN adhesion receptors have been proposed to have 
transmembrane functions, we examined whether an intracel- 
lular  perturbation  of /~,  subunit  of  integrins  might  also 
affect extraceUular matrix assembly. 
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Monovalent Antibodies against the Cytoplasmic Domain of 
the Integrin Bt Subunit 
Stages of development 
Time of  Morula  Gastrula 
development  124 cell  stage 5  stage 6  stage 7  stage 8a 
h  10-12  14  22  27  31 
MBS  -  +  ++  +++  ++++ 
Fab' nonimmune 
(50ng)  -  +  ++  +++  ++++ 
Anti-~COOH 
(2.5 ng)  -  +  ++  +++  ++++ 
(10 ng)  -  -  +  + +  + + + 
(25 ng)  ....  + 
(50 ng)  .....  /+ 
(100 ng)  ..... 
Various concentrations of anti-#~ cytoplasmic domain monovalent antibodies 
were injected into uneleaved Pleurodeles  waltl embryos.  They were reared at 
18"C in 10% MBS until they reached the indicated stage. The blastocoele roof 
was dissected,  fixed, and then  immunodetection of FN was performed.  For 
each point,  10 embryos were observed.  Quantities injected are expressed as 
nanograms  of antibodies  per  embryo.  MBS, sterile  injection  buffer;  anti- 
~COOH, monovalent antibodies against the cytoplasmic domain of the inte- 
grin B~ subunit; (-) no FN fibrils; (+) sparse FN fibrils at periphery of cells 
(as in Fig.  2 B); (++) FN fibrils all around  blastomeres  (as in Fig.  2 C); 
(+++)  FN  fibrils radially  arranged  on the  cell surface  (as  in  Fig.  2  D); 
(+ + + +) extensive,  anastomosed FN fibrils (as in Fig. 2 E). 
Monovalent  antibodies  were  injected  into  fertilized  eggs 
before the first cleavage. The results of intracytoplasmic in- 
jections  performed with antibodies  against the cytoplasmic 
domain  of integrin  13,  subunit  are  summarized  in  Table I. 
The  main  conclusion  is  that  these  monovalent  antibodies 
cause dose-dependent and reversible defects in FN-fibril for- 
mation. There is a slight inhibition of FN-fibril formation at 
10 ng of Fab'/embryo. This inhibition  is characterized  by a 
delay in the appearance of the first fibrils. Based on a sample 
of 10 embryos, this delay is estimated to be 7-8 h. With con- 
centrations ranging from 25 to 50 ng of Fab'/embryo, the de- 
lay in FN-fibril formation increased to  17-24 h.  In controls 
with injection buffer (10%  MBS),  or nonimmune FalY at 50 
ng/embryo,  a  normal  sequence  of FN-fibril  formation  oc- 
curred. 
An example of the defective extracellular matrix of FN ob- 
tained after injection of 50 ng Fab' fragments is presented in 
Fig.  4.  Observations  at early, mid-,  or late blastula (stages 
5,  6,  7) showed the same results,  i.e.,  no fluorescent fibrils 
were detected  on the  inner  surface of the blastocoele  roof 
(Fig. 4 A). It was not until the early gastrula stage (stage 8a) 
that the first fibrils appeared at the periphery of cells (Fig. 
4  B).  Their  distribution  was  identical  to  that  observed  in 
control embryos at the much earlier midblastula stage (stage 
6) (compare Figs. 4  B and 2  C).  Later,  FN-fibril formation 
was restored, but with a delay of '~ 24 h  in forming patterns 
that matched  those of control  embryos (Fig.  4  C). 
Antibodies  were also injected at the two-cell stage.  Fab' 
antibodies  (25  ng) were  introduced  into one blastomere in 
the presence of RLDx. The noninjected blastomere provides 
an internal control for each injection, and the labeled dextran 
permits  identification  of the  injected  blastomere  progeny. 
For  example,  Fig.  5  A  shows  an  external  view  of a  mid- 
Figure 4. Inhibition of FN-fibril formation by Fab' to cytoplasmic domain of integrin/3~  subunit. Monovalent antibodies against cytoplas- 
mic domain of integrin/3,  subunit (50 rig) were injected into uncleared embryo. Embryos were maintained at 18°C,  then dissected after 
the indicated times of incubation. Immunodetection of FN was then done on whole mounts of the bastocoele roof. (A) 24 h after injection, 
this embryo has reached the late blastula stage (stage 7), but no staining for FN can be detected.  (B) The first FN fibrils appear at the 
early gastrula stage (stage 8a). They are generally distributed around the periphery of cells. Their pattern is comparable to normal FN-fibril 
formation observed at early blastula stages (17 h earlier).  (C) Control involving injection of a mixture of anti-/3~ COOH antibodies and 
purified amphibian integrin/3t.  Immunodetection of FN was performed in the same time as in B. A well-developed FN meshv,~ark is re- 
vealed. Bar,  5 /~m. 
The Journal of Cell Biology, Volume  II0,  1990  1818 Figure 5. Inhibition of FN-fibril  formation in selected blastomeres by Fab' to cytoplasmic domain of integrin/3~ subunit.  Monovalent anti- 
bodies against the cytoplasmic domain of integrin/St  (25 ng/blastomere)  were injected  into one blastomere at the two-cell stage accompa- 
nied by lysinated  rhodamine dextran (RLDx, 50 mg/ml). The embryos were cultured at 18°C. At the indicated  stages,  the blastocoele 
roof was dissected, fixed, and immunofluorescent  detection of FN performed. (A) External view of living early blastula  embryo (stage 
6).  Under rhodamine illumination,  progeny of the injected  blastomere could easily be determined.  (B) Whole mounts of similar embryo 
as A when it reached the late blastula  stage (stage 7).  FN labeling  visualized  with fluorescein-specific  optics shows absence of FN from 
the surfaces  of rhodamine-labeled  cells,  while it was present in fibrillar  arrays on the surface of unlabeled  cells.  Bars: (A) 0.13 ram; (B) 
2.5 t~m. 
blastula stage (stage 6). It was injected at the two-cell stage 
with  RLDx  and  anti-/~  COOH  Fab'  (25  ng).  The  cells 
divided normally and progeny of  the injected blastomere was 
clearly  identifiable.  When  such  embryos  reached  the  late 
blastula stage (stage 7), the blastocoele roofs were dissected, 
fixed, and submitted to immunodetection of FN. Rhodamine- 
labeled cells lacked FN-fibrils on their inner cell surface. In 
the area of contact between  labeled  and unlabeled  blasto- 
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FN fibrils while neighboring unlabeled cells exhibited nor- 
mal extracellular fibrils (Fig. 5 B). The same results are ob- 
tained at later stages of development. Treated cells lacking 
FN fibrils were surrounded by extracellular matrix-contain- 
ing FN. 
To assess the specificity of this inhibition of FN-fibril for- 
mation,  we have performed five types of control experi- 
ments: (a) injection of nonimmune IgG of rabbit, mouse or 
human; (b)  RLDx alone; (c) RLDx plus nonimmune Fat/; 
(d) an absorption experiment with RLDx and Fat/prein- 
cubated with amphibian integrin ~  subunit; (e) RLDx plus 
Fat/mixed with the synthetic peptide used for immunizations. 
Injections of various nonimmune IgG as well as RLDx alone 
or Fat/preincubated with purified amphibian integrin B~ 
subunit had no deleterious effects on fibrillogenesis. Finally, 
we attempted to block the activity of Fat/by mixing them 
with the  synthetic peptide that was used as antigen; this 
probe itself produced a marked delay of the cleavage of la- 
beled cells, whereas progeny of  uninjected blastomere divid- 
ed normally. 
Experiments performed with exogenous iodinated or fluo- 
resceinated FN confirmed the above findings. First, 100 ng 
of anti-fl~ COOH Fat/were injected intracellularly into fer- 
tilized embryos. When injected embryos reached the early 
blastula stage (stage 5), a solution of 50/~g/ml (final amount, 
10 ng) of iodinated or fluoresceinated FN was injected into 
the blastocoele.  18 h later, when control embryos reached 
the early gastrula stage (stage 8a) radioactive binding data 
and immunofiuorescence observations revealed that exoge- 
nous FN was not detectably bound at the inner ectodermal 
cell surface of treated embryos (not shown). 
Development of  Embryos IntraceUularly 
Injected with Antibodies to Cytoplasmic Domain 
of  lntegrin [3~ Subunit 
Because injected embryos showed striking defects in FN- 
fibril formation, and because these fibrils provide a substrate 
for mesodermal cell migration (Boucaut et al.,  1984a,b; 
Darribere et al.,  1988),  we also studied the later develop- 
ment of injected living embryos. 
Comparisons of the timing of gastrulation in uninjected 
embryos and in eggs injected with anti-t, Fat/at different 
concentrations showed that in all cases, the formation of the 
dorsal lip of  the blastopore was unaffected. Nevertheless var- 
ious degrees of subsequent defects in gastrulation were ob- 
served.  The results obtained are summarized in Table II. 
They indicate that there is a variation not only in the percent- 
age of  embryos with defects but also in the severity of  the gas- 
trulation arrest. The three types of defects described are in 
agreement with those obtained when antibodies against avian 
integrins were injected into the blastocoele, i.e., extracellu- 
larly (Darribere et al., 1988). With low antibody concentra- 
tions (10 ng/embryo), no significant  perturbation of gastrula- 
tion could be observed. With 25 ng of  antibodies per embryo, 
which produces a delay of 7-8 h in FN-fibril formation (Fig. 
4, A and B), effects ranging from a slight delay to complete 
inhibition of gastrulation were obtained (Table II). More se- 
verely affected embryos were obtained in response to injec- 
tions of 100 ng of antibodies, 83% of the embryos showed 
complete inhibition of gastrulation (Table II). 
A series of injections were performed to introduce anti- 
Table II. Effects of  lntracellular Injection of  Antibodies to 
Cytoplasmic Domain of lntegrin {31 Subunit 
Amount of antibodies 





100  10  2 
2  70  83 
63  12  1 
12  2 
13  14  16 
Various amounts of monovalent antibodies to the cytoplasmic domain of inte- 
grin fl~ were injected  into fertilized  eggs. They were allowed to develop for 
60 h at 18°C and then observed. At this point (stage 14) normal embryos begin 
neurulation. Percent of defective embryos were pooled  from results obtained 
in four independent experiments containing 25 embryos. Type 1, no gastrula- 
tion, extensive convolution of the animal hemisphere. Type H, no gastrnlation, 
slight convolution of the animal hemisphere. Type 111, delay in gastrulation, 
small circular yolk plug. 
bodies preferentially into lateral blastomeres of developing 
embryos.  The  results  showed that intracytoplasmic injec- 
tions of anti-/~ COOH Fat/produced lateral defects of FN- 
fibril formation, which could be well correlated with a delay 
in mesodermal cell migration. The most obvious and consis- 
tent defects were found when neural folds failed to form 
properly. This was demonstrated by coinjecting 100 ng of  an- 
tibodies and RLDx into one blastomere at the two-cell stage, 
in which case one-half of the neurula is derived from the in- 
jected cell. The labeled half of the embryo failed to form 
neural folds whereas the contralateral control was normal 
(Fig. 6). 
Discussion 
In this report, we provide new evidence that the integrin/~, 
subunit and the Arg-Gly-Asp recognition signal are essential 
for FN-fibril formation in vivo. Our major results are: (a) in- 
terspecies injection of exogenous FN into the blastocoele of 
living  embryos  still  permits  assembly  into  extracellular 
fibrils with the same time-dependent pattern as endogenous 
FN; (b) fibril formation from exogenous FN is prevented by 
both RGD-containing peptides and polyclonal Fat/to the 
whole/3~  subunit of amphibian integrin applied extracellu- 
larly;  (c)  intracytoplasmic injections of antibodies to the 
carboxy-terminal domain of/~ produce a reversible matrix 
assembly defect; and (d) defective mesodermal cell migra- 
tion occurs in areas of embryos devoid of FN-fibrils as a re- 
sult of antibody injection. 
Before testing the ability of blastomeres to assemble exog- 
enous FN into fibrils, we reexamined the kinetics of for- 
The Journal of Cell Biology, Volume 110,  1990  1820 Figure 6.  Embryos injected with antibodies to cytoplasmic domain of integrin/3~ subunit. (A) Embryo at the two-cell stage was injected 
into the left blastomere with 100 ng of anti-/3~ COOH Fab'. At the time of observation 72 h later, the left neural fold is defective. (B) Con- 
trol experiment. Anti-/3, COOH Fab' were preincubated with amphibian integrin ~  and injected into the left blastomere at the two-cell 
stage. Neurulation occurs normally. Bar, 0.3 mm. 
mation of the FN-containing extracellular matrix.  Careful 
examination shows a reproducible, progressive, spatiotem- 
poral organization of FN fibrils. In early blastulae (stage 5), 
they appear first at the periphery of blastomeres.  Later on 
(by stage 7), they also appear over the surface of the central 
portion of cells. This pattern of formation is consistent with 
results described for cultured fibroblasts. For example, when 
fibroblasts were seeded onto FN-substrata, they apparently 
organized FN into fibrils from the periphery to the center of 
cells (Avnur and Geiger,  1981; Grinnell, 1986). This result 
is also in agreement with our recent observations of  FN-fibril 
formation in Rana pipiens embryos (Johnson et al.,  1990). 
When exogenous labeled FNs were injected into the blas- 
tocoele at the initiation of FN-fibril formation, we were able 
to observe matrix assembly. Iodinated and fluoresceinated 
FNs were incorporated into fibrils in a slow time-dependent 
manner. The stage-dependent kinetics of FITC-FN assembly 
into fibrils is comparable with that for endogenous FN-fibril 
formation. It should be noted that fibril formation from exog- 
enous FN is specific and saturable, because an excess of un- 
labeled FN prevents matrix assembly of labeled FN.  Fur- 
thermore, on FN fibrils transferred to slides, no exogenous 
labeled FN is assembled into fibrils. This last observation 
suggests that in our experimental system, preexisting FN fi- 
brils do not act as a primer for spontaneous exogenous FN 
fibrillogenesis and also that a direct cell surface interaction 
is needed. These results in vivo are generally consistent with 
those  found  using  fibroblast  model  systems  (McDonald, 
1988), although this system displays a stage-specific regula- 
tion of FN assembly. Interestingly, we also find that in living 
embryos, endodermal blastomeres are unable to organize 
FN into fibrils even in the presence of excess labeled FN. 
This result indicates cell-type specificity of matrix assembly. 
The experimental system developed here thus provides a 
useful model for studies of FN-fibril formation in vivo. We 
have used this in vivo system to evaluate whether the integrin 
13,  subunit is essential for FN-fibril formation. 
We demonstrated that the assembly of exogenous FN by 
animal  blastomeres is  prevented both by RGD-containing 
peptides  and  by  antibodies  to  the  amphibian  /3,  subunit. 
The simplest interpretation of these results is that FN-fibril 
formation in vivo requires the extracellular domain of inte- 
grin/~,  subunit.  Moreover, the sensitivity to inhibition by 
an RGD-containing peptide suggests that the FN receptor 
(integrin VLA-5) is the molecule responsible, although the 
concurrent involvement ofa FN-binding vitronectin receptor 
cannot be formally excluded. This is, to our knowledge, the 
first report that FN matrix assembly can be inhibited by RGD- 
containing peptides.  Previous work with fibroblast model 
systems in vitro indicates that high levels of the large cell-ad- 
hesive domain of FN will partially inhibit assembly (McDon- 
ald et al., 1988), but the sensitivity to inhibition found in the 
present study was unexpectedly high. In fibroblasts in vitro, 
the non-cell-adhesive amino-terminal domain appears to play 
a particularly central role in FN binding to the postulated 
matrix assembly receptor. It is of interest that in similar ex- 
periments with human fibroblasts in vitro that have already 
initiated matrix assembly, RGD peptides do not cause any in- 
hibition of FN binding to the matrix assembly receptor (Fo- 
gerty, E  J.,  and D.  E  Mosher,  personal communication), 
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ent mechanism. In this amphibian developmental system, the 
data suggest that the integrin (FN-receptor) system mediates 
not only the process of cell attachment and migration (Bou- 
caut et al.,  1984a,b; Nakatsuji and Johnson, 1984b;  Darri- 
bore et al.,  1988) but also mediates or modulates FN-fibril 
formation during extracellular matrix assembly. In fact, some 
of previously reported inhibition of gastrulation  in this sys- 
tem after injection of synthetic peptides (Boucaut et al., 1984b) 
may involve inhibition  of assembly of the fibrils necessary 
for mesodermal cell migration. 
Intracellular injection of monovalent antibodies  to the cy- 
toplasmic domain of integrin/~  subunit into fertilized  eggs 
or into blastomeres results in direct  inhibition of FN-fibril 
formation only in their progeny. Injections  of IgG fractions 
from rabbit,  mouse, and human sera or Fab' preadsorbed 
with amphibian integrin #~ subunit have not produced such 
changes  in  FN-fibril  formation.  These  controls  indicate, 
respectively,  that cytotoxic or nonspecific effects of antibod- 
ies are not responsible for the defects observed. These results 
represent the first direct injection evidence that the cytoplas- 
mic domain of an integrin is essential for its function in vivo. 
One obvious mechanism by which these antibodies could in- 
hibit FN matrix assembly is by disrupting  integrin/~t  sub- 
unit interactions with the cytoskeleton. There is morpholog- 
ical and functional evidence that FN fib, ils may interact with 
the microfilament system via the fibronectin receptor. In cul- 
tured fibroblasts, microfilament bundles, ~actinin, and talin 
at least partially  co-align with clusters of FN receptor  (/~ 
integrins; Chen et al.,  1985; Damsky et al.,  1985). Disrup- 
tion of FN-receptor interactions  using synthetic peptides or 
monoclonal antibodies against the -5 or ~L subunits of the 
FN receptor results in decreased microfilament bundle orga- 
nization  (Chen et al.,  1986;  Akiyama  et al.,  1989a).  Bio- 
chemical observations  suggest that there is direct interaction 
between detergent-solubilized  chick integrin and talin, albeit 
with a low affinity (Horwitz et al., 1986). This binding is in- 
hibited by a peptide corresponding to the cytoplasmic domain 
of integrin/~ subunit (Buck and Horwitz,  1987).  Another 
possibility is that antibodies prevent the noncovalent associa- 
tion of ~i~ with the ,~  subunit,  which is needed  for ligand 
specificity. 
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